Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Novel Treatment Strategies for Sphingosine-1-Phosphate Therapeutics to Manage Patients with Moderate to Severe Ulcerative Colitis

Program Overview

This CME/CE activity will highlight novel treatment strategies for sphingosine-1-phosphate (S1P) therapeutics to manage patients with moderate to severe ulcerative colitis (UC). The expert faculty, led by Dr. David T. Rubin, will first review the need for new therapeutics in ulcerative colitis, including treatment goals and unmet needs. Next, the faculty will analyze the science of S1P receptor ...
View Course
Applying S1P Therapeutics to Improve Outcomes for Patients with Moderate to Severe Ulcerative Colitis

Program Overview

This CME activity is derived from content presented at the Digestive Disease Week (DDW) 2021 Virtual Meeting. The expert faculty will highlight sphingosine-1-phosphate (S1P) therapeutics to improve outcomes for patients with moderate to severe ulcerative colitis (UC). Additionally, a review of S1P receptor modulators as a therapeutic target to support the management of ulcerative colitis will be discussed ...
View Course
Advances in Patient-Controlled On-Demand Treatment of Paroxysmal Supraventricular Tachycardia

Program Overview

Unpredictable episodes of paroxysmal supraventricular tachycardia (PSVT) often have a negative impact on patient quality of life by causing uncomfortable, disconcerting symptoms during episodes (e.g., palpitations, chest pain, dizziness, syncope, shortness of breath, anxiety), by imposing restrictions on patient activities, and by potential association with medication-related side effects. Among commercially insured patients, healthcare spending increases substantially following diagnosis ...
View Course
Applying New Science to Patient-Focused Treatment Strategies Across the Spectrum of Multiple Sclerosis

Program Overview

This CME/CE activity is derived from content presented at the 6th Annual Advanced Curriculum for Multiple Sclerosis 2021 Virtual CME/CE Course. The expert faculty, led by Dr. Fred D. Lublin, will first review the science of the evolving spectrum of multiple sclerosis (MS) to better understand the course of MS disease activity, as well as optimal treatment solutions ...
View Course
Applying New Science to Symptom Management Across the Spectrum of Multiple Sclerosis

Program Overview

This CME/CE activity is derived from content presented at the 6th Annual Advanced Curriculum for Multiple Sclerosis 2021 Virtual CME/CE Course. The expert faculty, led by Dr. Fred D. Lublin, will first provide an overview of comorbidities in multiple sclerosis (MS), as well as primary, secondary and tertiary symptoms. Cannabis/cannabinoid use in MS will be reviewed and efficacy ...
View Course

Upcoming Events

Alliance 46th Annual Conference

July 14th – 16th, 2021

CME/CE Symposium at the Congress of Clinical Rheumatology East Meeting

August 13th, 2021

CME/CE Symposium at the Congress of Clinical Rheumatology West Meeting

September 19th, 2021

2021 Consortium of Multiple Sclerosis Centers Annual Meeting

October 25th – 28th, 2021